Boxer Capital Management’s KalVista Pharmaceuticals KALV Stock Holding History

Boxer Capital Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,400	Closed	-$411K	–	64
2026 Q1	$411K	Hold	20,400	–	–	0.05%	52
2025 Q4	$329K	Hold	20,400	–	–	0.07%	42
2025 Q3	$248K	Sell	20,400 -73,000	-78%	-$1.01M	0.08%	32
2025 Q2	$1.06M	Buy	+93,400	New	+$1.14M	0.53%	17
2025 Q1	–	Sell	-1,590,000	Closed	-$13.5M	–	42
2024 Q4	$13.5M	Buy	+1,590,000	New	+$16.5M	1.15%	27

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Boxer Capital Management's KALV Position: Q2 2026 in Review

Boxer Capital Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 20,400 shares — an estimated $411K sold.

Boxer Capital Management first reported a position in KALV in Q4 2024 and held it in 5 quarters. The position peaked at $13.5M in Q4 2024. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Boxer Capital Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Boxer Capital Management sold 20,400 KalVista Pharmaceuticals shares in Q2 2026, an estimated $411K.
Boxer Capital Management first reported a position in KalVista Pharmaceuticals in Q4 2024 and held it in 5 quarters.
Boxer Capital Management's KalVista Pharmaceuticals position peaked at $13.5M in Q4 2024.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Boxer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.